113 related articles for article (PubMed ID: 37724012)
21. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B
Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594
[TBL] [Abstract][Full Text] [Related]
22. Comparison of survival outcomes of locally advanced cervical cancer by histopathological types in the surveillance, epidemiology, and end results (SEER) database: a propensity score matching study.
Tian T; Gong X; Gao X; Li Y; Ju W; Ai Y
Infect Agent Cancer; 2020; 15():33. PubMed ID: 32435273
[TBL] [Abstract][Full Text] [Related]
23. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
24. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
[TBL] [Abstract][Full Text] [Related]
25. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
Wang X; Lu X; Chen J; Yi H; Lan Q
BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
[TBL] [Abstract][Full Text] [Related]
26. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
Alleyne-Mike K; van Wijk L; Hunter A
Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
[TBL] [Abstract][Full Text] [Related]
27. The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer.
Grover S; Showalter S; Kraft KH; Suneja G; Lin L
Int J Gynecol Cancer; 2013 Mar; 23(3):494-9. PubMed ID: 23388613
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
29. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of adenocarcinoma histology in women with cervical cancer.
Galic V; Herzog TJ; Lewin SN; Neugut AI; Burke WM; Lu YS; Hershman DL; Wright JD
Gynecol Oncol; 2012 May; 125(2):287-91. PubMed ID: 22266551
[TBL] [Abstract][Full Text] [Related]
31. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
Mabuchi S; Komura N; Sasano T; Sakata M; Matsuzaki S; Hisa T; Kamiura S; Morishima T; Miyashiro I
Curr Oncol; 2023 Oct; 30(11):9428-9436. PubMed ID: 37999102
[TBL] [Abstract][Full Text] [Related]
32. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y; Zhang G; Li Z; Chen B; Zhao H; Yang Y; Wang L; Yao J; Chen X; Huang Y; Lang J; Liu P; Chen C
Cancer Med; 2023 Oct; 12(19):19617-19632. PubMed ID: 37768092
[TBL] [Abstract][Full Text] [Related]
33. Survival benefits with the addition of adjuvant hysterectomy to radiochemotherapy for treatment of stage I-II adenocarcinoma of the uterine cervix.
Huang XB; Zhang WW; Wu SG; Sun JY; He ZY; Zhou J
J Surg Oncol; 2018 Sep; 118(3):574-580. PubMed ID: 30114328
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
35. Can the histopathology influence the outcome of early-stage cervical cancer?
Jonska-Gmyrek J; Zolciak-Siwinska A; Gmyrek L
Eur J Gynaecol Oncol; 2016; 37(2):178-81. PubMed ID: 27172741
[TBL] [Abstract][Full Text] [Related]
36. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
38. Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Jeong DH
Int J Gynecol Cancer; 2017 Jul; 27(6):1228-1236. PubMed ID: 28604449
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
[TBL] [Abstract][Full Text] [Related]
40. Association of pretreatment SUV
Shou H; Yasuo Y; Yuan S; Lou H; Ni J
Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
